Comprehensive Bioinformatics Analysis for the Identification of Hub Genes and Critical Signaling Pathways Differentiating Latent and Active Tuberculosis.

IF 1.7 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Wu Peng, Wenlai Li, Jie Qiu, Sijing Huang, Mei Li, Zhenzhen Zhao, Mengyuan Lyu, Mengjiao Li, Xingbo Song
{"title":"Comprehensive Bioinformatics Analysis for the Identification of Hub Genes and Critical Signaling Pathways Differentiating Latent and Active Tuberculosis.","authors":"Wu Peng, Wenlai Li, Jie Qiu, Sijing Huang, Mei Li, Zhenzhen Zhao, Mengyuan Lyu, Mengjiao Li, Xingbo Song","doi":"10.2174/0113862073401054250526094910","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Population with Latent tuberculosis infection (LTBI) is the principal source of active tuberculosis (ATB) cases. The identification of reliable diagnostic biomarkers is critical for the prevention and control of the progression from LTBI to ATB. The aim of this study is to screen biomarkers that can distinguish LTBI from ATB patients by using a comprehensive bioinformatics analysis strategy.</p><p><strong>Methods: </strong>The transcriptomic datasets were obtained from the GEO database. Hub genes and critical signal pathways for differentiating latent and active TB, were identified by a comprehensive bioinformatics analysis strategy comprising Weighted Gene Co-Expression Network Analysis (WGCNA), Differentially Expressed Gene (DEG), Protein-Protein Interaction (PPI), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and hub genes were verified by RT-qPCR in this study.</p><p><strong>Results: </strong>The transcriptome profiles of GSE193777, GSE157657, GSE168519, GSE107991, and GSE107992 were extracted from the GEO database, in which a total of 18,397 protein-coding genes from 206 samples were included in the bioinformatics analysis. Combined with Weighted Gene Co-Expression Network, differentially expressed gene, functional enrichment, and proteinprotein interaction analyses, six hub genes were identified. The results of RT-qPCR confirmed that the expression levels of four hub genes (HLA-DOA, ECH1, PARN and TRAPPC4) were downregulated in the LTBI group compared with the ATB group.</p><p><strong>Conclusion: </strong>Our findings may provide crucial clues to potential biomarkers that can distinguish patients with LTBI from those with ATB, aiding the understanding of the mechanism underlying the progression of LTBI to ATB.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Combinatorial chemistry & high throughput screening","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113862073401054250526094910","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Population with Latent tuberculosis infection (LTBI) is the principal source of active tuberculosis (ATB) cases. The identification of reliable diagnostic biomarkers is critical for the prevention and control of the progression from LTBI to ATB. The aim of this study is to screen biomarkers that can distinguish LTBI from ATB patients by using a comprehensive bioinformatics analysis strategy.

Methods: The transcriptomic datasets were obtained from the GEO database. Hub genes and critical signal pathways for differentiating latent and active TB, were identified by a comprehensive bioinformatics analysis strategy comprising Weighted Gene Co-Expression Network Analysis (WGCNA), Differentially Expressed Gene (DEG), Protein-Protein Interaction (PPI), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and hub genes were verified by RT-qPCR in this study.

Results: The transcriptome profiles of GSE193777, GSE157657, GSE168519, GSE107991, and GSE107992 were extracted from the GEO database, in which a total of 18,397 protein-coding genes from 206 samples were included in the bioinformatics analysis. Combined with Weighted Gene Co-Expression Network, differentially expressed gene, functional enrichment, and proteinprotein interaction analyses, six hub genes were identified. The results of RT-qPCR confirmed that the expression levels of four hub genes (HLA-DOA, ECH1, PARN and TRAPPC4) were downregulated in the LTBI group compared with the ATB group.

Conclusion: Our findings may provide crucial clues to potential biomarkers that can distinguish patients with LTBI from those with ATB, aiding the understanding of the mechanism underlying the progression of LTBI to ATB.

鉴别潜伏性和活动性结核病枢纽基因和关键信号通路的综合生物信息学分析。
目的:潜伏结核感染人群(LTBI)是活动性结核(ATB)病例的主要来源。确定可靠的诊断性生物标志物对于预防和控制从LTBI到ATB的进展至关重要。本研究的目的是通过综合生物信息学分析策略筛选可以区分LTBI和ATB患者的生物标志物。方法:转录组学数据从GEO数据库中获取。本研究采用加权基因共表达网络分析(WGCNA)、差异表达基因(DEG)、蛋白-蛋白相互作用(PPI)、基因本体(GO)和京都基因与基因组百科全书(KEGG)等综合生物信息学分析策略,对枢纽基因和区分潜伏性和活动性结核病的关键信号通路进行了鉴定,并采用RT-qPCR对枢纽基因进行了验证。结果:从GEO数据库中提取了GSE193777、GSE157657、GSE168519、GSE107991和GSE107992的转录组图谱,共纳入206个样本的18397个蛋白编码基因进行生物信息学分析。结合加权基因共表达网络、差异表达基因、功能富集和蛋白互作分析,鉴定出6个枢纽基因。RT-qPCR结果证实,与ATB组相比,LTBI组4个枢纽基因(HLA-DOA、ECH1、PARN和TRAPPC4)的表达水平下调。结论:我们的研究结果可能为区分LTBI患者和ATB患者的潜在生物标志物提供重要线索,有助于理解LTBI向ATB发展的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
5.60%
发文量
327
审稿时长
7.5 months
期刊介绍: Combinatorial Chemistry & High Throughput Screening (CCHTS) publishes full length original research articles and reviews/mini-reviews dealing with various topics related to chemical biology (High Throughput Screening, Combinatorial Chemistry, Chemoinformatics, Laboratory Automation and Compound management) in advancing drug discovery research. Original research articles and reviews in the following areas are of special interest to the readers of this journal: Target identification and validation Assay design, development, miniaturization and comparison High throughput/high content/in silico screening and associated technologies Label-free detection technologies and applications Stem cell technologies Biomarkers ADMET/PK/PD methodologies and screening Probe discovery and development, hit to lead optimization Combinatorial chemistry (e.g. small molecules, peptide, nucleic acid or phage display libraries) Chemical library design and chemical diversity Chemo/bio-informatics, data mining Compound management Pharmacognosy Natural Products Research (Chemistry, Biology and Pharmacology of Natural Products) Natural Product Analytical Studies Bipharmaceutical studies of Natural products Drug repurposing Data management and statistical analysis Laboratory automation, robotics, microfluidics, signal detection technologies Current & Future Institutional Research Profile Technology transfer, legal and licensing issues Patents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信